Cleared Traditional

QUANTITATIVE DETERMINATION OF PORPHYRINS (K780455) - FDA 510(k) Clearance

Class I Chemistry device.

K780455 · Whale Scientific, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1978
Decision
129d
Days
Class 1
Risk

K780455 is an FDA 510(k) clearance for the QUANTITATIVE DETERMINATION OF PORPHYRINS. Classified as Fluorometric Measurement, Porphyrins (product code JKJ), Class I - General Controls.

Submitted by Whale Scientific, Inc. (Mchenry, US). The FDA issued a Cleared decision on July 27, 1978 after a review of 129 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1595 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Whale Scientific, Inc. devices

Submission Details

510(k) Number K780455 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 20, 1978
Decision Date July 27, 1978
Days to Decision 129 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
41d slower than avg
Panel avg: 88d · This submission: 129d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JKJ Fluorometric Measurement, Porphyrins
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1595
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.